Related Experiment Video
Updated: Jun 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Signal pathways in ouabain-induced proliferation of leukemia cells
Jia-Wei Xu1, Run-Ming Jin, En-Qin Li
1Pediatric Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Background:
Cardiotonic steroids (CTSs) can bind to Na(+)/K(+)-ATPase and activate protein kinase cascades, resulting in changes in cell proliferation, differentiation or apoptosis in a cell-specific manner. We explored the participation of ouabain-activated signaling pathways in growth regulation of leukemia cells.
Methods:
Lymphocytic leukemia Jhhan cells and megakaryocytic leukemia M07e cells were incubated at different concentrations of ouabain (0, 1 and 10 nmol) for 24 hours. Cell proliferation was measured by methyl thiazolyl tetrazolium (MTT) assay. To probe the role of ouabain-induced signaling in control of cell growth, we employed Src kinase inhibitor PP2 and the MEK inhibitor PD98059, respectively. The expression of Na(+)/K(+)-ATPase alpha1 subunit of leukemia cells was evaluated by RT-PCR and Western blotting.
Results:
One nmol and 10 nmol ouabain promoted proliferation of both Jhhan and M07e cells. Ouabain also up-regulated the expression of Na(+)/K(+)-ATPase alpha1 subunit. Addition of either PP2 or PD98059 blocked the effects of ouabain on cell proliferation.
Conclusion:
Ouabain activates Src and ERK1/2 pathways and regulates the proliferation of leukemia cells.
Insights
Ouabain, a cardiotonic steroid, promotes leukemia cell proliferation by activating Na(+)/K(+)-ATPase and associated signaling pathways like Src and ERK1/2.
Area of Science:
- Cellular Biology
- Molecular Biology
- Oncology
Background:
- Cardiotonic steroids (CTSs) interact with Na(+)/K(+)-ATPase, modulating cell signaling pathways.
- These pathways influence cell proliferation, differentiation, and apoptosis in a cell-specific manner.
Purpose of the Study:
- To investigate the role of ouabain-activated signaling pathways in regulating leukemia cell growth.
- To understand the specific mechanisms by which ouabain affects leukemia cell proliferation.
Main Methods:
- Incubation of lymphocytic leukemia (Jhhan) and megakaryocytic leukemia (M07e) cells with varying ouabain concentrations.
- Assessment of cell proliferation using MTT assay.
- Inhibition of Src kinase (PP2) and MEK (PD98059) to probe signaling pathways.
- Evaluation of Na(+)/K(+)-ATPase alpha1 subunit expression via RT-PCR and Western blotting.
Main Results:
- Ouabain (1 and 10 nmol) significantly promoted proliferation in both Jhhan and M07e leukemia cell lines.
- Ouabain treatment led to an up-regulation of the Na(+)/K(+)-ATPase alpha1 subunit expression.
- Inhibitors PP2 and PD98059 effectively blocked ouabain's proliferative effects on leukemia cells.
Conclusions:
- Ouabain activates the Src and ERK1/2 signaling pathways in leukemia cells.
- These activated pathways play a crucial role in regulating leukemia cell proliferation.
- Targeting these pathways may offer novel therapeutic strategies for leukemia.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Second Messengers
Non-Canonical Wnt Signaling Pathways

